ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Delaware » Internal Medicine

Top Internal Medicine Prescribers in Delaware

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RITU RASTOGI MD

Internal Medicine

21,178

$1.09M

398
352 are 65+

20%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $79

BESHARA HELOU MD

Internal Medicine

18,249

$1.62M

642
465 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $79

KENNETH SMITH MD

Internal Medicine

13,609

$895K

542
405 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $79

ODILON CLARAVALL M.D.

Internal Medicine

12,895

$861K

449
352 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $79

SAMBHAB KUMAR MD

Internal Medicine

12,314

$655K

404
288 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $79

AVANI VIRANI MD

Internal Medicine

11,988

$673K

224
196 are 65+

20%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $79

FABRICIO ALARCON M.D.

Internal Medicine

11,768

$816K

456
269 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $79

FADI DAMOUNI MD

Internal Medicine

11,053

$831K

613
448 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 28%

$75
Average prescription price

Avg: $79

MARK EVANGELISTA M.D.

Internal Medicine

8,870

$666K

487
351 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$75
Average prescription price

Avg: $79

PING-AN TJOA M.D.

Internal Medicine

8,741

$411K

311
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 28%

$47
Average prescription price

Avg: $79

FRED KAHN MD

Internal Medicine

8,512

$479K

382
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $79

JERRY GLUCKMAN MD

Internal Medicine

8,415

$598K

464
391 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$71
Average prescription price

Avg: $79

BHASKAR PALEKAR M.D.

Internal Medicine

8,120

$774K

587
537 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

2%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 28%

$95
Average prescription price

Avg: $79

STEPHEN WETHERILL M.D.

Internal Medicine

8,098

$820K

497
475 are 65+

2%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 28%

$101
Average prescription price

Avg: $79

SETH IVINS MD

Internal Medicine

7,918

$751K

328
179 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 28%

$95
Average prescription price

Avg: $79

UDAY JANI M.D.

Internal Medicine

7,914

$835K

557
498 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 28%

$106
Average prescription price

Avg: $79

EDWARD MCCONNELL MD

Internal Medicine

7,627

$922K

415
350 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 28%

$121
Average prescription price

Avg: $79

GREGORY BEATO D.O.

Internal Medicine

7,426

$527K

503
350 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 28%

$71
Average prescription price

Avg: $79

DAVID MAGED MD

Internal Medicine

7,099

$529K

379
356 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $79

FREDERICK SAMSEL M.D.

Internal Medicine

7,082

$361K

280
242 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $79

RAJSHEKAR NARASIMAIAH M.D.

Internal Medicine

6,795

$519K

394
353 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $79

CARLOS REYES MD

Internal Medicine

6,765

$651K

391
347 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 28%

$96
Average prescription price

Avg: $79

LYNN ROMANO M.D.

Internal Medicine

6,617

$394K

348
265 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$60
Average prescription price

Avg: $79

SANDEEP MANN M.D.

Internal Medicine

6,585

$582K

398
254 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$88
Average prescription price

Avg: $79

MONIQUE YOST M.D.

Internal Medicine

6,557

$431K

271
188 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $79

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank